Armata Pharmaceuticals (ARMP) Other Non-Current Liabilities (2013 - 2019)

Armata Pharmaceuticals has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $1.3 million for Q4 2019.

• Other Non-Current Liabilities for Q4 2019 came in at $1.3 million, up 20.59% year-over-year; the trailing twelve-month figure through Dec 2019 was $1.3 million (up 20.59% YoY), and the FY2019 annual result was $1.3 million, up 20.59% from the prior year.
• Other Non-Current Liabilities came in at $1.3 million for Q4 2019 at Armata Pharmaceuticals, up from $1.2 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $14.7 million in Q1 2015 to a low of $2000.0 in Q1 2016.
• The 5-year median for Other Non-Current Liabilities is $1.2 million (2019), against an average of $1.8 million.
• Across the five-year window, Other Non-Current Liabilities slumped 99.99% in 2016 and jumped 116350.0% in 2017, its largest moves.
• Armata Pharmaceuticals' Other Non-Current Liabilities stood at $1.5 million in 2015, then surged by 62.98% to $2.4 million in 2016, then tumbled by 88.05% to $292000.0 in 2017, then surged by 282.53% to $1.1 million in 2018, then grew by 20.59% to $1.3 million in 2019.
• The last three Other Non-Current Liabilities figures came in at $1.3 million (Q4 2019), $1.2 million (Q3 2019), and $1.2 million (Q1 2019), per Business Quant data.